Investigates miR-34a-5p's role and potential as a biomarker in lumbar disc herniation, suggesting implications for treatment strategies.
This study aimed to investigate the expression, clinical significance, and underlying molecular mechanism of miR-34a-5p in Lumbar disc herniation (LDH). A total of 112 patients with LDH and 112 healthy controls were enrolled. Serum miR-34a-5p expression was measured by RT-qPCR, and its diagnostic value was assessed using receiver operating characteristic curve analysis. The correlations of miR-34a-5p with clinical indicators and inflammatory factors were analyzed. In vitro, an IL-1β-induced inflammatory injury model of human nucleus pulposus cells (HNPCs) was established to verify the function of miR-34a-5p. Serum miR-34a-5p was markedly upregulated in patients with LDHmiR-34a-5p was positively correlated with disease severity, the Visual Analogue Scale, Oswestry Disability Index, Pfirrmann grade, TNF-α, IL-1β, IL-6, and negatively correlated with Japanese Orthopaedic Association score and IL-10. In vitro, IL-1β upregulated miR-34a-5p in HNPCs; miR-34a-5p overexpression aggravated the inhibition of cell viability and the inflammatory response, whereas its knockdown alleviated these effects. Mechanistically, miR-34a-5p directly targeted and suppressed ZBTB20 mRNA expression. miR-34a-5p is highly expressed in LDH and may serves as a promising diagnostic biomarker. It promotes HNPC inflammatory injury and LDH progression by targeting ZBTB20.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: